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Technological advances in magnetic resonance imaging (MRI) and computed tomography (CT), including higher spatial and
temporal resolution, have made the prospect of performing absolute myocardial perfusion quantification possible, previously
only achievable with positron emission tomography (PET). This could facilitate integration of myocardial perfusion biomarkers
into the current workup for coronary artery disease (CAD), as MRI and CT systems are more widely available than PET
scanners. Cardiac PET scanning remains expensive and is restricted by the requirement of a nearby cyclotron. Clinical evidence
is needed to demonstrate that MRI and CT have similar accuracy for myocardial perfusion quantification as PET. However, lack
of standardization of acquisition protocols and tracer kinetic model selection complicates comparison between different studies
and modalities. The aim of this overview is to provide insight into the different tracer kinetic models for quantitative myocardial
perfusion analysis and to address typical implementation issues in MRI and CT. We compare different models based on their
theoretical derivations and present the respective consequences for MRI and CT acquisition parameters, highlighting the interplay
between tracer kinetic modeling and acquisition settings.
1. Introduction
Myocardial perfusion imaging (MPI) is commonly used to
investigate myocardial ischemia. While different modalities
for MPI have different diagnostic accuracy, the overall
accuracy to diagnose hemodynamically significant coronary
artery disease (CAD) is good [1]. Analysis of MPI results
in the clinical setting is mostly performed by visual evalu-
ation of presence and pattern of hypoenhancement of the
myocardium during first-pass of intravenously injected con-
trast. Presence of regions with normal perfusion is essential
for this method to work. This is a limitation for diagnosis of
patients with multivessel disease or balanced ischemia [2].
MPI can only distinguish multivessel disease and balanced
ischemia when quantitative measures of myocardial perfu-
sion are provided.
Positron emission tomography (PET) was the first tech-
nique to establish quantitative measures for perfusion. In
PET, time-resolved acquisition of the first-pass of tracer
uptake and direct quantification of tracer concentration
were developed. With those parameters quantified, tracer
kinetic modeling (1-compartment or 2-compartment mod-
eling) could be applied to produce independent estimates
of perfusion in stress and rest, known as absolute perfusion
measurement (mL/g/min).This technique has been validated
using microsphere comparison [2–4]. Furthermore, added
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clinical value beyond relative and visual perfusion analysis
has been demonstrated [5–8]. The myocardial perfusion
reserve (MPR), calculated from PET-derived perfusion mea-
surement at stress and rest, was shown to be an important
predictor of cardiovascular events [9–11].
A limitation of cardiac PET is the relatively high cost and
the need for an on-site cyclotron, depending on the tracer.
Recent developments with the new 18F-tracer flurpiridaz
or other improved tracers could obviate the need for an
on-site cyclotron. Flurpiridaz has shown good linearity of
myocardial uptake with perfusion at a large flow range,
excellent myocardial retention, low background noise in
adjacent organs, and a relatively long half-life (110min) [12].
Magnetic resonance imaging (MRI) and computed
tomography (CT) imaging could be important modalities
to compete with PET for the complete workup of cardiac
patients. Recent developments have sparked interest for
myocardial perfusion quantification using these techniques.
State-of-the-artMRI and CT have better spatial and temporal
resolution compared to PET. Integration of MRI and CT
into current workup for coronary artery disease (CAD)
also profits from their wider availability, lower costs, and
increasing clinical role in comprehensive diagnosis of CAD.
The validity and noninferiority of MRI and CT compared
to PET measurements need to be demonstrated before a
decision regarding the preference for MRI or CT over PET
for myocardial perfusion quantification can be reached.
Lack of standardized acquisition and modeling protocols for
myocardial perfusion acquisition have complicated compar-
ison between studies and modalities.
The aim of this study is to provide insight into the tracer
kinetic models in absolute myocardial perfusion quantifi-
cation, and their implementation requirements for CT and
MRI. A further aim was to analyze the factors that influence
myocardial perfusion quantification.
2. Myocardial Perfusion Imaging in
MRI and CT
Perfusion refers to the delivery of blood to the tissue via
the intravascular capillary pathway. Perfusion imaging uses
dynamic contrast-enhanced acquisition to observe the first-
pass dynamics of contrast agent delivery into the tissue of
interest over time. For myocardial perfusion quantification,
the first-pass contrast dynamics at the respective supplying
artery or other arterial input sites should be captured as well.
The typical arterial input sites for myocardial perfusion are
the left ventricular cavity in MRI or the descending aorta in
CT.
2.1. Contrast Agent. MRI and CT use different agents
(gadolinium and nonionic iodine, resp.) to acquire contrast
in the myocardial perfusion scans: both small molecules
(<1 kDa, typical particle diameters of 0.82 nm for gadolinium
dimeglumine and 1.4 nm of iohexol) that distribute to the
interstitial space and generally do not enter the intracellular
space. Actually, MRI contrast agents do interact with the
intracellular space by changing the relaxivity of water that
diffuses freely into the cell. The diffusion constants for MRI
andCT contrast agents are roughly similar: 2.7× 10−2m2/s for
gadolinium dimeglumine, and 2.5 × 10−2m2/s for iohexol [13,
14]. Although the nonionic iodine contrast agents typically
have a much higher viscosity compared to gadolinium,
neither CT nor MRI contrast agents have significant effects
on the viscosity of the blood stream [15, 16]. Gadolinium-
based contrast agents have limited linearity of contrast
enhancement to contrast concentration, with higher dose
resulting in blood signal saturation [17, 18]. A typical dose
of gadolinium contrast for visual and quantitative analysis
is 0.05mmol/kg at an injection rate of 4-5mL/s. Dosages as
low as 0.03mmol/kg body weight have been recommended
to prevent contrast saturation both in the myocardium and
in the arterial input function [19]. Iodine-based contrast
agents on the other hand have more straightforward and
steady linearity of contrast enhancement to contrast con-
centration, which greatly simplifies absolute quantification
[20]. In myocardial perfusion studies with multidetector CT,
iodine contrast agents are administered at an injection rate of
3–5mL/s and a volume of 60–70mL [21, 22]. The resulting
lengthy administration of CT contrast (longer than the first-
pass of diffusion), however, violates the principles of indicator
dilutor theory and will affect the accuracy of quantification.
2.2. Acquisition of Myocardial Perfusion Imaging. In MRI,
myocardial perfusion imaging is mainly based on T1-
weighted pulse sequences, where interactions of paramag-
netic gadolinium (Gd3+) with surrounding water molecules
result in lower T1 relaxation times of the protons involved,
resulting in signal enhancement showing as hyperintensity on
the T1-weighted image, reflecting the distribution of gadolin-
ium [23]. The current protocol allows acquisition of three
myocardial short-axis slices at every heartbeat with a typical
spatial resolution of 1.5 × 1.5 × 10mm3, performed during
50–60 consecutive heartbeats. In dynamic contrast-enhanced
MRI, temporal resolution generally is in the order of 1 sec (1-
2 cardiac cycles). Recently introduced advanced accelerated
imaging sequences achieve whole heart 3D perfusion MRI
with a voxel resolution of 2.3 × 2.3 × 5mm3, although
with their reduced temporal resolution not a substitute for
quantitative estimation of myocardial blood flow [24]. In
CT, with dynamic shuttling mode acquisition, whole heart
coverage with higher spatial resolution can be obtained (0.3
× 0.3 × 5mm3) at every 2-3 heartbeats [22]. In contrast, CT
scanners with wider detectors, of up to 16 cm, can achieve
whole heart acquisition in a single heartbeat [25]. In both
methods, perfusion imaging is performed over 20–30 con-
secutive heartbeats. CT has a high temporal resolution. The
latest generation of dual-source CT scanners has a temporal
resolution per acquisition of approximately 63ms. However,
dual-source CT scanners need to shuttle between two posi-
tions, resulting in a time interval in-between scans of once
every second heartbeat and, for high heart rhythms, once
every three cardiac cycles.The 256- and 320-sliceCT scanners
have lower temporal resolution per acquisition (in the order
of 135ms), but these scanners do not have to shuttle between
two positions in order to acquire information about thewhole
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heart, providing the opportunity to image at every heartbeat
(at the cost of higher dose). A limitation in CT, and especially
also in dynamic CT perfusion studies, is that the radiation
dose is directly related to the number of images acquired. For
a thorough overview of CT perfusion acquisition techniques
one is referred to the review by Rossi et al. [26].
2.3. Why Use Modeling in MRI and CT. In theory, tis-
sue perfusion can be inferred from the apparent contrast
enhancement without any complex modeling, assuming that
the contrast agent is hemodynamically inert. This hypothesis
holds true if two criteria are met with (1) a linear relationship
between contrast enhancement and contrast concentration
(ex vivo linearity) and (2) a linear relationship between
apparent contrast enhancement and perfusion (in vivo/uptake
linearity).
Ex vivo linearity is present in PET tracers as well as in
CT iodine-based contrast agents regardless of their concen-
trations and in MR gadolinium only up to a certain con-
centration limit [17, 18]. In vivo/uptake linearity is limited in
case of extravasating contrast agent. Most contrast agents in
perfusion imaging do not only flow to the intravascular space
but also distribute to the extracellular extravascular space
(EES). Only in case EES extraction fraction is constant within
the range of physiological perfusion flow, the apparent con-
trast enhancement will be linear to perfusion, as is the case
with 15O-water and 18F-flurpiridaz in PET. However, in most
tracers such as 13N-ammonia [12, 23, 27], 82Rb-rubidium
[12, 23], gadolinium [23, 28–30], and iodine [23, 31, 32],
the extraction fractions decrease nonlinearly with increasing
perfusion, causing reduced in vivo/uptake linearity.
To correct for the effect of these extravasating tracers
or contrast agents on contrast enhancement, tracer kinetic
modeling attempts to separate the dynamics of contrast agent
in the intravascular space and the EES over time to yieldmore
accurate perfusion estimation. These modeling techniques
have been successfully applied in PET myocardial perfusion
imaging with different tracers, including 13N-ammonia and
82Rb-rubidium [33]. It is theoretically feasible to implement
the same principles in MRI and CT, using tracer kinetic
modeling.
3. Tracer Kinetic Modeling
Tracer kinetic modeling essentially relates the dynamics of
tracer or contrast agent concentration in tissue (myocardium)
to that in the supplying artery referred to as arterial input
function (AIF).The contrast dynamics over time are obtained
by tracing the myocardium and AIF voxels from the dynamic
contrast-enhanced acquisition (Figure 1).
The mathematical relation between contrast dynamics
in the tissue and in the AIF is represented by an impulse
response function (IRF) (Figure 2). As a result of a one
unit-amplitude of an infinitely narrow input bolus (impulse
bolus) in the arterial inlet (Figure 2(a)), contrast retention
will occur in the tissue with a certain dynamic proportion
in time, defined as IRF (Figure 2(b)). In a perfusion imaging
study, the AIF can be considered as a train of time-shifted
and magnitude-scaled impulse boluses (Figure 2(c)) produc-
ing a corresponding train of time-shifted and magnitude-
scaled IRFs in the tissue (Figure 2(d)). An iterative curve-
fitting operation called deconvolution can then be applied to
reconstruct the IRF from the AIF and tissue enhancement
curves. Since deconvolution may lead to more than one
mathematically suitable solution, it is necessary to restrict
the operation by requiring the IRF to follow a certain
parameterized formulation specific for each perfusionmodel.
Therefore, perfusion flow is estimated from those IRF param-
eters providing the best fit at deconvolution.
4. Different Tracer Kinetic Models
Tracer kinetic models for absolute myocardial perfusion
quantification can be classified into three model groups:
distributed parameter, compartmental, and indicator dilution
theory approaches, each of which has been developed into
more specific models. For thorough explanation of the
distributed parameter and compartmental models one is
referred to the technical paper by Sourbron and Buckley
and two manuscripts by Jerosch-Herold for the indicator
dilution theory approach [34–36]. In the present overview
those modeling approaches are solely compared on the basis
of physical interpretation of their respective IRF.
For extravasating contrast agents as used in MRI and CT,
contrast agent molecules distribute across two spaces, that is,
the intravascular space and the EES (Figure 3). Each space is
defined by volume, rate, and transit time parameters.The rel-
ative intravascular plasma space is defined as the intravascu-
lar plasma volume relative divided by total tissue volume (V
𝑝
).
The intravascular flow rate (𝐹) equals the blood perfusion rate
per unit of volume of tissue and the mean capillary transit
time (MTT
𝑐
) is the ratio between the blood volume and the
tissue blood perfusion rate. Similarly, the tissue interstitial
volume (V
𝑒
) is the sum of extravascular extracellular space
(EES) volume contained in a volume of tissue. The two-way
exchange rate to and from the EES is called the permeability-
surface product, PS, and the MTT
𝑒
is the mean transit time
for the EES. Additionally, an extraction fraction (𝐸) describes
the proportion of the contrast agent distributing to the EES.
IRF is affected by the inflow of contrast (perfusion), two-way
exchange of contrast between plasma and the EES, extraction
fraction, and permeability. High-order perfusion models
take into account such dynamics as completely as possible,
although assumptions remain and additional variables do
not necessarily yield more accurate results. The lower order
models assume some parameters or dynamics to be negligible
compared to others, thus simplifying the model. In Figure 4
each modeling approach is illustrated, with the formulation
presented in Table 1.
5. Models Based on Axially
Distributed Parameters
5.1. Distributed Parameter Model. This model takes into
account the most detailed aspects of contrast dynamics at
the tissue level. It assumes contrast concentration within the
4 BioMed Research International
Table 1: Tracer kinetic model formulation.
Model Output parameters Impulse response function (IRF)







𝑒 Not available in time domain
Tissue homogeneity 𝐹, 𝐸, MTT𝑐, V𝑝, V𝑒
Adiabatic approximation of tissue














𝐸𝐹 exp−(𝐸𝐹/V𝑒)(𝑡), 𝑡 > 𝐹
V
𝑝
2-compartment 𝐹, PS, V𝑝, V𝑒
See Figure 5(b)
IRF (𝑡) = 𝐹 exp−(𝐹/V𝑝)(𝑡) + PS exp−(PS/V𝑒 )(𝑡)
1-compartment (Extended Toft’s) 𝐾trans, V𝑝, V𝑒
See Figure 5(c)





1-compartment (Toft’s) 𝐾trans, V𝑒 (assuming V𝑝 ≪ V𝑒)
See Figure 5(d)
IRF(𝑡) = 𝐾trans exp
−(𝐾trans/V𝑒)(𝑡)
Fermi 𝐹, MTT𝑐, 𝑘 (in extravasating contrastagent, only 𝐹 is of physiological value)
See Figure 5(e)
IRF (𝑡) = 𝐹
exp𝑘(𝑡−MTT𝑐) + 1
Model-independent deconvolution 𝐹 (estimated as initial IRF magnitude) No specific formulation
𝐹: perfusion rate.
PS: extracellular extravascular space (EES) exchange rate.
MTT𝑐: capillary mean transit time.
MTT𝑒: EES mean transit time.
V𝑝: EES volume fraction.
V𝑒: intravascular plasma volume fraction.
𝐾trans: compound transfer constant (perfusion and EES exchange).
𝑘: venous clearance rate for intravascular contrast agent.
























Figure 1: Myocardial (green voxels) and arterial input function (red voxels) tracing to produce contrast dynamics time curves.
intravascular space and EES to be varying temporally and
axially along the longitudinal direction of the perfusion flow
(Figure 4(a)). As such, themodel is able to estimate every vol-
ume, rate, and time parameter specified in the intravascular
and the interstitial space, as well as the extraction fraction.
Thedistributed parametermodel has been applied to estimate
MRI stress/rest myocardial perfusion in healthy volunteers
[37].
5.2. Tissue Homogeneity Model. This model by Johnson and
Wilson assumes that the contrast concentration only varies
longitudinally in the intravascular space and not in the
EES (Figure 4(b)) [38]. With this assumption, the model
loses the ability to estimate the time parameter of the EES
(MTT
𝑒
) but can still estimate the other intravascular and
EES parameters.These two axially distributedmodels require
special numerical treatments for model fitting (i.e., multiple
or Laplace-domain fitting) due to their complexity [39, 40].
5.3. Adiabatic Approximation of Tissue Homogeneity Model.
Developed by Lawrence andLee, thismodel further simplifies
the tissue homogeneity model by assuming that the contrast
























Figure 2: Single arterial inlets are shown with different magnitude scale in different time instance (a) and the respective magnitude-scaled
impulse response function (IRF) in the tissue (b). A contrast bolus can be modeled as trains of arterial inlets (c), producing trains of
magnitude-scaled IRF in the tissue (d). Deconvolution aims to reconstruct the IRF that fits the relation between the red and green lines






Figure 3: Illustration of contrast agent (blue dots) distribution in
the tissue: V
𝑝
is the plasma volume within the intravascular space,
V
𝑒
is the extravascular extracellular space, 𝐹 is the perfusion flow
within the intravascular space, and PS is the permeability-surface




. Another parameter, the extraction
fraction (𝐸), denotes the proportion of contrast agent exchanged to
the extravascular extracellular space.
exchange between the intravascular space and the EES only
takes place in the venous outlet [41]. Therefore, the rate of
concentration change in the EES is much slower than in
the intravascular space (Figure 4(c)). Adiabatic model fitting
can be performed as a standard time-domain deconvolution
with IRF, as specified in Table 1: height and length of the
plateau correspond to perfusion flow and capillary mean
transit time (MTT
𝑐
), respectively, while the decay rate of the
monoexponential function represents the venous clearance.
This model was first proposed in brain studies but has been
used in oncological and cardiac studies afterwards [42–46].
5.4. Implementation Issues. The main limitations for axially
distributedmodels are (1) the need of a fast acquisition rate to
support MTT
𝑐
estimation and (2) the more complicated and
noise-sensitive fitting methods. Faster perfusion produces
shorter MTT
𝑐
, requiring more compact contrast bolus to
accurately capture the MTT
𝑐
from the contrast dynamics.
6. Models Based on Compartments
The main difference between the compartmental and axially
distributed model lies in the assumption that intravascular
and EES contrast agent concentrations only vary with time,
and not axially (Figures 4(d) and 4(e)). Because the axial con-
trast concentration gradient is considered negligible, transit
time cannot be estimated, limiting themodeling results to the
volume and rate parameters.
6.1. 2-Compartmental and 1-Compartmental Model. The
typical IRF of a 2-compartment model takes the shape of
a biexponential function, without an initial plateau for the
capillary inflow phase due to the absence of transit time





PS: EES-plasma exchange rate
: extracellular extravascular space (EES) volume fractione
: intravascular plasma volume fractionp
F: perfusion rate
PS: EES-plasma exchange rate
: extracellular extravascular space (EES) volume fractione
: intravascular plasma volume fractionp
Figure 4: Schematic representation of different tracer kinetic models: (a) distributed parameter model, (b) tissue homogeneity model, (c)
adiabatic approximation of tissue homogeneity model, (d) 2-compartment model, (e) 1-compartment (Toft’s) model, and (f) Fermi model.
estimation. The faster-decaying exponential refers to the
transfer towards the EES while the slower exponential refers
to the transfer from the EES. On the other hand, the IRF of a
1-compartment model takes the shape of a monoexponential
function. The maximum magnitude of the IRF corresponds
to 𝐾trans, a compound tissue transfer constant formulated
by multiplying perfusion (𝐹) by the contrast extraction
fraction (𝐸) [47]. Three main 1-compartmental models are
distinguished.
6.2. Toft’s Models. The basic Toft’s model refers specifically
to immediate and complete tracer extraction fraction (𝐸 =




, such that 𝐾trans repre-
sents perfusion flow [47]. Since V
𝑝
is not negligible in the
myocardium, one study applied an Extended Toft’s model
where V
𝑝
is added to the original IRF [47, 48]. However, it
has been argued that, under the Extended Toft’s model,𝐾trans
is closer to the EES exchange rate than to the perfusion flow
[49].
6.3. Patlak Model. The Patlak model includes only data
portions from the early phase of contrast arrival, when
the contrast agent has not significantly filled the EES yet.
Here, EES contrast concentration is not adequate to cause
diffusion of contrast molecules back to the intravascular





a single compartment with a single transfer rate (𝐾trans)
[50]. The temporal growth in the EES contrast concentration
will be linear to the rate of contrast transfer to the EES
(𝐾trans) and the AIF contrast concentration. Therefore,𝐾trans
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Figure 5
of the Patlak model can be reconstructed from the slope of
a correlation map between tissue contrast concentration and
the area under the curve of the AIF. However, care should be
taken to make sure that only appropriate data portions are
used.The Patlak model has been used in humanMRI studies
of myocardial perfusion, with an acquisition rate matching
every heartbeat, as well as in animals with the acquisition rate
matching every other heartbeat [30, 48, 51].
6.4. Maximum Slope Method. The maximum slope method
is derived from exactly the same assumptions as the Patlak
model, therefore requiring the same portion of data points
and suffering the same concerns.The Patlak-equivalent𝐾trans
is derived by normalizing the maximum slope of the tissue
concentration to the maximum (peak) concentration of the
AIF.The tissue maximal upslope is calculated by linear fitting
while the AIF peak is derived from gamma-variate fitting.
The method has been implemented in an older study based
on electron-beam CT as well as in more recent myocardial
perfusion studies with dual-source CT [21, 52–54].
6.5. Implementation Issues. The main critique on the 1-
compartmentmodel is that𝐾trans is amultiplication of extrac-
tion fraction (𝐸) and perfusion instead of a sole perfusion
(𝐹) indicator. A limited number of MRI studies have shown a
nonlinearly decreasing extraction suggesting a limited range
of𝐾trans proportionality with perfusion if this parameter is to
be derived from gadolinium [18, 28–30]. Correcting𝐾trans for
the extraction fraction (𝐸) improved the correlation between
Patlak-derived𝐾trans andmicrosphere perfusion in an animal
experiment [51].
7. Models Based on Indicator Dilution Theory
7.1. The Fermi Model. The Fermi model was initially devel-
oped for studies with a purely intravascular indicator. Assum-
ing an axially varying contrast concentration in the intravas-
cular space, it was observed that the IRF of an intravascular
indicator resembled the shape of the Fermi function [19, 55].
The amplitude, width of initial plateau, and subsequent curve
decay rate of the fitted Fermi function represent perfusion,
capillary mean transit time, and venous clearance rate,
respectively (Table 1). For extravasating tracers, the validity of
the Fermi model holds as long as the tracer concentration in





), a condition assumed to be attainable in the first-
pass of tracer circulation [36].TheFermimodel has been used
in many MR human and animal studies [2, 36, 56–60] and it
has been used in one CT porcine study [32].
7.2. Model-Independent Deconvolution. The previous perfu-
sion models have been driven by specific physical assump-
tions on the distribution of contrast agent in the tissue, cul-
minating into exact IRF formulation. A model-independent
approach attempts to overcome these tissue-specific assump-
tion problems by applying more generic mathematical con-
straints in the IRF calculation. With the central-volume
principle applied in the indicator dilution theory, the initial
8 BioMed Research International
magnitude of the IRF is then assumed as perfusion regardless
of the shape of the IRF [19, 35]. Studies with high data qual-
ity have shown excellent agreement of model-independent
deconvolution with true perfusion (simulation study) and
microspheres (porcine study, 𝑛 = 3), as well as with PET in
healthy volunteers (𝑛 = 5) [35, 61].
7.3. Implementation Issues. Since the indicator dilution
approach does not presume any separation between the
intravascular and the EES contrast dynamics, its perfusion
estimation is uncorrected for EES exchange. Therefore, the
same concern as in 1-compartment models, that is, the con-
sistency of perfusion representation over the physiological
range of perfusion, also applies to indicator dilution theory
models.
8. Influence of Different Acquisition Settings
In the previous paragraphs, the different perfusion models
were discussed. Those models offer different degrees of
perfusion evaluation. When more accurate quantification of
perfusion is desired, consequently,more detailed information
of contrast dynamics is required.This leads to more demand-
ing acquisition settings (i.e., faster acquisition rate, higher
contrast-to-noise ratio). As a result, more detailed models
are more sensitive to noise, because a small change in the
contrast dynamics will have more impact on the parameter
estimations.
8.1. Key Acquisition Factors. Jerosch-Herold performed a
thorough review on specificMRI requirements [19]. Minimal
requirements of several general key acquisition/image quality
parameters that influence the output of tracer kinetic models
are listed here.
(1) A compact contrast bolus is needed to ensure that
the contrast dynamics contains information as requested by
the modeling. An increasingly dispersed bolus is known to
cause increasing perfusion underestimation and variability,
especially at higher flow rate [62]. As a rough guidance, the
contrast bolus should be compact enough to accommodate a
clear definition of the peak enhancement in the AIF as well as
in the tissue (and even more compact in case of the use of the
axially distributed model). A gadolinium injection rate of at
least 3mL/s, and optimally 4mL/s, has been recommended
for MRI myocardial perfusion assessment [18, 63]. More
prominent bolus dispersion can be expected in CT due to the
typically larger injected contrast volume.
(2) In order to estimate the flow rate and transit time
parameters, a sufficiently fast acquisition rate (temporal
resolution) is needed to capture the fastest change described
by the model. When only the flow rate parameter is analyzed,
the minimum scan interval is determined by the time-to-
peak (TTP) of the AIF. When both rate and transit time
parameters are concerned, the mean capillary transit time
(MTT
𝑐
) determines the minimum scan interval. In other
tissues a considerable underestimation was found when the
temporal resolution was reduced, with both CT and MRI
[62, 64–68].
(3) In order to estimate volume parameters, the acquisi-
tion period should be at least within the order of the transit
time parameter of the concerned volume, to ensure proper
capture of the arrival and clearance of contrast agent.
(4) In-plane spatial resolution should be adequate to
prevent partial volume effects, especially if voxel-wise tracer
kinetic modeling is to be applied. In the data acquisition
this means that voxels are best small and isotropic (cubic
rather than rectangular, etc.). This is hard to realize in MRI
where the in-plane spatial resolution is approximately 5 times
lower than in CT (1.5 × 1.5mm versus 0.3 × 0.3mm) with
slice thickness much larger than in-plane resolution. In post-
processing, the quantification resolution particularly worsens
due to partial volume effects in CT where investigators have
typically analyzed the CT perfusion in slices thicker than the
native resolution.
(5) Signal-to-noise ratio (SNR) concerns the total vari-
ability in the contrast dynamics. Small variations in con-
trast dynamics may influence the precision of tracer kinetic
modeling. The use of higher Tesla machines in MRI may
provide better SNR without compromising spatiotemporal
resolution, although inherent problems with RF homogene-
ity can adversely impact quantification. Implementation of
higher tube current in CT can also improve SNR by reducing
variability in contrast dynamics and the error inmodel fitting
[19, 55]. A disadvantage of higher tube current is the increase
in radiation dose. A decrease in tube voltage could increase
SNR, because of the 𝐾-edge of iodine, which lies around
35 kV. If possible, a lower tube voltage would be beneficial for
contrast scans and additionally lowers radiation dose [69].
9. Clinical Implication and Conclusion
Regarding the choice of model used, we suggest that one
should use the simplest possible model that can explain the
contrast dynamics. It is worth noting that the use of higher-
order models will only be beneficial when the acquisition
is optimized to capture the additional contrast dynamic
details requested by the model. Considering the current
imaging and contrast administration setup for MRI and
CT myocardial perfusion imaging, the 1-compartmental and
Fermi models seem to be the most technically applicable.
Axially distributed models require an acquisition rate at
the order of MTT
𝑐
and a sufficiently compact bolus to
identify the capillary inflow phase. Balancing such demand
with clinical requirements for spatial resolution and coverage
could be problematic. Apart from optimal data quality,
model-independent deconvolution also requires knowledge
for selection of the regularization parameter, which may not
be available in every imaging center.
Issues for clinical adoption go beyond the accuracy of the
quantitative myocardial perfusion value itself. The assump-
tions made by each model are coupled with the theoretical
pitfalls we have tried to identify in our appraisal.
The major complication with quantitative MR perfusion
is in the limited linearity of contrast enhancement to contrast
concentration, requiring lower dose of gadolinium, thus
compromising the accuracy of visual analysis as well as
the precision of perfusion estimation. CT perfusion on the
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other hand greatly simplifies quantification efforts by offering
a linear relationship between contrast enhancement and
concentration. However, current CT imaging setup suffers
reduced image quality due to the shuttling mode acquisition
and limited temporal resolution as well as acquisition period
due to the radiation dose constraint; both reduce the preci-
sion and accuracy of perfusion estimation.
Limited studies have mentioned instability issues of
higher-order models. More investigations are required [37,
70]. Reproducibility of perfusion values is highly related to
the imaging quality, where specific issues such as acquisi-
tion/reconstruction artifacts need to be taken care of in both
modalities before implementing the model.
An important issue for the clinical setting would be to
establish the expected physiological variability across differ-
ent subjects, so that the usability of quantitative myocardial
perfusion in diagnostic or sequential observation setting
can be verified. Quantitative PET studies for instance have
shown considerable heterogeneity inmyocardial perfusion of
healthy volunteers, related to factors such as age, gender, rate-
pressure product, and other hemodynamic factors [71, 72].
Furthermore, in the presence of COPD and hypertension, the
value of myocardial perfusion reserve has been shown to be
impaired without regional myocardial ischemia [73–75]. The
spectrum of physiological variability inmyocardial perfusion
should also be investigated with MRI and CT if myocardial
perfusion quantification is to be adopted in clinical practice.
Studies investigating the performance of quantitative
MRI andCTmyocardial perfusion imaging in detectingCAD
have been conducted with different reference standards, that
is, stenosis diameter, derived from either quantitative CT
or invasive coronary angiography, fractional flow reserve, or
even visual analysis of SPECTmyocardial perfusion. None of
these reference parameters actually capture the same func-
tional phenomenon as myocardial perfusion.The anatomical
aspect of a stenosis does not describe its functional relevance,
while fractional flow reserve, even though being a functional
parameter, indicates the hemodynamics of the focal coronary
lesion rather than its systemic effect on myocardial micro-
circulation. The quantitative relationship between myocar-
dial perfusion and the above parameters, therefore, can be
expected to be affected by broader physiological variability,
which may be better captured by quantitative analysis than
by visual assessment. However, the superiority of quantitative
myocardial perfusion over mere visual analysis for diagnosis
of hemodynamically significant CAD still needs to be proven.
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